GB839876A - A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus - Google Patents

A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus

Info

Publication number
GB839876A
GB839876A GB31043/56A GB3104356A GB839876A GB 839876 A GB839876 A GB 839876A GB 31043/56 A GB31043/56 A GB 31043/56A GB 3104356 A GB3104356 A GB 3104356A GB 839876 A GB839876 A GB 839876A
Authority
GB
United Kingdom
Prior art keywords
virus
canine hepatitis
infectious canine
liquid
plus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB31043/56A
Inventor
Arnold Howard Fieldsteel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLIED LAB Inc
Original Assignee
ALLIED LAB Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALLIED LAB Inc filed Critical ALLIED LAB Inc
Priority to GB31043/56A priority Critical patent/GB839876A/en
Publication of GB839876A publication Critical patent/GB839876A/en
Priority to MY196590A priority patent/MY6500090A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/235—Adenoviridae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10361—Methods of inactivation or attenuation
    • C12N2710/10364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A process for preparing a vaccine for immunizing dogs against infectious canine hepatitis comprises propagating an inoculum of an infectious canine hepatitis virus that has been attenuated by at least fifty serial passages in tissue cultures selected from dog kidney, testicle and/or uterus, in a similar tissue culture in a nutrient liquid, incubating until there has been sufficient growth of attenuated virus to produce a useful concentration, and harvesting a liquid material containing the virus. The liquid material may be administered per se, or dried from the frozen state and diluted with a suitable liquid, e.g. distilled water, p normal saline solution, for use. The nutrient liquid may be Earle's balanced salt solution (herein defined) plus lactalbumin hydrolysate plus inactivated horse serum, or Medium No. 199 (herein defined) plus inactivated horse serum, while the tissue culture may be one of dog kidney or uterus in Medium No. 199.
GB31043/56A 1956-10-11 1956-10-11 A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus Expired GB839876A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB31043/56A GB839876A (en) 1956-10-11 1956-10-11 A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
MY196590A MY6500090A (en) 1956-10-11 1965-12-31 Improvements in or relating to the moulding of concrete components

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31043/56A GB839876A (en) 1956-10-11 1956-10-11 A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus

Publications (1)

Publication Number Publication Date
GB839876A true GB839876A (en) 1960-06-29

Family

ID=10317093

Family Applications (1)

Application Number Title Priority Date Filing Date
GB31043/56A Expired GB839876A (en) 1956-10-11 1956-10-11 A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus

Country Status (2)

Country Link
GB (1) GB839876A (en)
MY (1) MY6500090A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074119A1 (en) * 1981-09-09 1983-03-16 Bertram Dr. Flehmig Hepatitis-A viruses adapted to human fibroblast cells
CN109777786A (en) * 2017-11-15 2019-05-21 中国农业科学院特产研究所 Fox source canine adenovirus Ⅰ velogen strain and its application

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074119A1 (en) * 1981-09-09 1983-03-16 Bertram Dr. Flehmig Hepatitis-A viruses adapted to human fibroblast cells
CN109777786A (en) * 2017-11-15 2019-05-21 中国农业科学院特产研究所 Fox source canine adenovirus Ⅰ velogen strain and its application
CN109777786B (en) * 2017-11-15 2023-03-03 中国农业科学院特产研究所 Fox source dog I type adenovirus virulent strain and application thereof

Also Published As

Publication number Publication date
MY6500090A (en) 1965-12-31

Similar Documents

Publication Publication Date Title
GB1161333A (en) Animal Vaccine
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
ES373631A1 (en) Live attenuated marek{40 s disease virus vaccine for poultry
Melnick et al. Stabilized Suspensions of Monkey Kidney Cells Suitable for Intercontinental Shipment.
Owen et al. Bluetongue in cattle: typing of viruses isolated from cattle exposed to natural infections
GB839876A (en) A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus
GB1071922A (en) Improvements in or relating to vaccines
Greig et al. Cultivation in tissue culture of an infectious agent from coital exanthema of cattle. A preliminary report
Laufs Immunisation of marmoset monkeys with a killed oncogenic herpesvirus
Seeley et al. Inheritance and longevity of infectious pancreatic necrosis virus in the zebra fish, Brachydanio rerio (Hamilton-Buchanan)
Chomiak et al. Tissue culture and chicken embryo techniques for infectious laryngotracheitis virus studies
US3057783A (en) Infectious bovine rhinotracheitis vaccine and method of preparing it
US3098011A (en) Process of producing a vaccine against distemper
GB878704A (en) Propagation of attenuated infectious canine hepatitis virus in trypsinized tissue cultures of pig kidney and the preparation of a vaccine therefrom
GB930451A (en) Process for propagating rabies virus
Soret et al. In vitro method for cultivating eastern equine encephalomyelitis virus in teleost embryos.
GB1276218A (en) Calf diarrhea virus vaccine and processes
US2204064A (en) Equine encephalomyelitis vaccine
US3122477A (en) Hog cholera vaccine and method of making the same
Hwang Duck hepatitis virus in duck embryo fibroblast cultures
Parker et al. Propagation of rabies virus in tissue culture.
US4004974A (en) Live virus culture vaccine against carnivore distemper and method of producing same
Zinsser et al. Further Studies of Agar-slant Tissue Cultures of Typhus Rickettsiæ.
ES496780A0 (en) A PROCEDURE FOR IN VITRO CELL CULTIVATION OF THE HEPATITIS B VIRUS.
GB1058340A (en) Transmissible gastroenteritis vaccines and method of producing the same